Skip to main content
Clinical Trials/NCT02708264
NCT02708264
Unknown
Not Applicable

Pessary in Prevention of Preterm Birth for Women With Twin Pregnancies and Short Cervical Length

Federico II University1 site in 1 country242 target enrollmentMarch 1, 2016
ConditionsPreterm Birth

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Preterm Birth
Sponsor
Federico II University
Enrollment
242
Locations
1
Primary Endpoint
Spontaneous Preterm delivery <34 weeks
Last Updated
7 years ago

Overview

Brief Summary

Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. Multiple gestations are at increased risk of SPTB. A short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB, in both singletons and twins.

The cervical pessary is a silicone device that has been used to prevent SPTB. The efficacy of the cervical pessary has been assessed in several populations including singletons with short CL, unselected twins, twins with short CL, and triplet pregnancies. Several randomized clinical trials (RCTs) have been published, and several are ongoing. However, no consensus on use of the cervical pessary in pregnancy or guidelines for management have been assessed.

Registry
clinicaltrials.gov
Start Date
March 1, 2016
End Date
March 2021
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Federico II University
Responsible Party
Principal Investigator
Principal Investigator

Gabriele Saccone

Medical Doctor

Federico II University

Eligibility Criteria

Inclusion Criteria

  • 18-50 years of age
  • Twin pregnancy (limits the participants to female gender)
  • Short cervical length (less than or equal to 30 mm) on second trimester ultrasound at 18-23 6/7 weeks gestation

Exclusion Criteria

  • Singleton or higher order than twins multiple gestation
  • Monoamniotic twins
  • Twin twin transfusion syndrome
  • Ruptured membranes
  • Lethal fetal structural anomaly
  • Fetal chromosomal abnormality
  • Cerclage in place (or planned placement)
  • Vaginal bleeding
  • Suspicion of chorioamnionitis
  • Ballooning of membranes outside the cervix into the vagina

Outcomes

Primary Outcomes

Spontaneous Preterm delivery <34 weeks

Time Frame: Less than 34 weeks gestation

Secondary Outcomes

  • Spontaneous rupture of membranes(Less than 34 weeks gestation)
  • Type of delivery (if cesarean or operativa vaginal or spontaneous vaginal delivery)(Time of delivery)
  • Composite perinatal outcome(Between birth and 28 days of age)
  • Birth weight(Time of delivery)
  • Neonatal death(Between birth and 28 days of age)
  • Maternal side effects(Maternal side effects)
  • Gestational age(Time of delivery)
  • Spontaneous preterm birth rates <37, <28 and <24 weeks(Less than 24, 28, 34 and 37 weeks gestation)

Study Sites (1)

Loading locations...

Similar Trials